Roots Analysis has done a detailed study on Prefilled Syringes, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

To order this 800+ page report, which features 800+ figures and 150+ tables, please visit this link

Key Market Insights
 Presently, around 80 types of prefilled syringes are available in the market, and several companies claim to be engaged in the manufacturing of both glass and plastic variants of such versatile drug delivery solutions
 Over 140 drugs and vaccines have either been marketed or have undergone clinical investigation (since 2013) for delivery via prefilled syringes for the treatment of a variety of disease indications
 In order to gain a competitive edge in the market, prefilled syringe manufacturers are actively engaged in developing patient friendly products, with improved safety features and solutions
 The market is also characterized by the presence of many contract service providers, spread across the world, offering fill / finish services in prefilled syringes
 Several big pharma companies are actively engaged in strengthening their pipeline of injectable drugs across various therapeutic areas
 An evaluation of 280+ marketed and pipeline products revealed that a variety of drugs / product candidates are likely to be considered for administration via prefilled syringes in the near future, paving way for new partnerships
 The current market opportunity is well distributed across different therapeutic areas, molecule types and geographical regions; the market is likely to grow at a steady pace over the coming years
 Glass, single chamber prefilled syringes dominate the current market; however, the demand for plastic devices is anticipated to witness a relatively higher growth in the foreseen future

For more information, please visit https://www.rootsanalysis.com/reports/view_document/prefilled-syringes-market/284.html

Table of Contents

1. PREFACE
1.1. Chapter Overview
1.2. Scope of the Report
1.3. Research Methodology
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION TO PREFILLED SYRINGES
3.1. Chapter Overview
3.2. History of Prefilled Syringes
3.3. Benefits of Prefilled Syringes Over Traditional Injectable Devices
3.3.1. Benefits for Healthcare Professionals and End Users
3.3.2. Benefits to Manufacturers
3.3.3. Shift from Existing Dosage Forms to Prefilled Syringes

3.4. Prefilled Syringe Components
3.5. Classification of Prefilled Syringes
3.5.1. Classification by Barrel Fabrication Material
3.5.1.1. Glass
3.5.1.1.1. Limitations of Glass Barrel Prefilled Syringes
3.5.1.1.2. Addressing the Limitations of Glass Barrel Prefilled Syringes

3.5.1.2. Plastic
3.5.1.2.1. Limitations of Plastic Barrel Prefilled Syringes
3.5.1.2.2. Addressing the Limitations of Plastic Barrel Prefilled Syringes
3.5.1.2.3. Factors Likely to Drive the Use of Plastic Barrel Prefilled Syringes

3.5.2. Classification by Number of Chambers in the Barrel
3.5.3. Classification by Type of Needle System
3.5.4. Classification by Type of Packaging

3.6. Critical Attributes of Prefilled Syringe Design
3.7. Manufacturing Prefilled Syringes
3.7.1. Production of Barrels
3.7.1.1. Glass Barrel Prefilled Syringes
3.7.1.2. Plastic Barrel Prefilled Syringes
3.7.2. Production of Syringes
3.7.3. Barrel Siliconization
3.7.4. Syringe Sterilization
3.7.5. Validation of Sterilization
3.7.6. Syringe Filling
3.7.7. Syringe Testing
3.8. Future of Prefilled Syringes

4 PREFILLED SYRINGES: MARKET OVERVIEW
4.1. Chapter Overview
4.2. Prefilled Syringes: List of Available / Under Development Devices
4.2.1. Analysis by Type of Barrel Fabrication Material
4.2.2. Analysis by Number of Barrel Chambers
4.2.3. Analysis by Type of Needle System
4.2.4. Analysis by Device Capacity

4.3. Prefilled Syringes: List of Developers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Geographical Location of Headquarters
4.3.4. Analysis by Geographical Location of Manufacturing Facilities

4.4. Technological Developments in Prefilled Syringes

5 PRODUCT COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Methodology
5.3. Assumptions and Key Parameters
5.4. Product Competitiveness Analysis: Prefilled Syringe Systems
5.4.1. Glass Barrel Prefilled Syringes
5.4.2. Plastic Barrel Prefilled Syringes

6 MANUFACTURERS OF PREFILLED SYRINGES
6.1. Chapter Overview
6.2. Key Prefilled Syringe Manufacturers Based in North America
6.2.1. Becton Dickinson
6.2.1.1. Company Overview
6.2.1.2. Financial Performance
6.2.1.3. Prefilled Technology Solutions
6.2.1.4. Glass Barrel Prefilled Systems
6.2.1.4.1. BD Hypak Prefilled Syringe
6.2.1.4.2. BD Neopak Prefilled Syringe
6.2.1.4.3. BD Hylok Prefilled Syringe
6.2.1.5. Plastic Barrel Prefilled Systems
6.2.1.5.1. BD Sterifill Syringe Systems
6.2.1.6. Other Prefilled Delivery Systems
6.2.1.6.1. BD Uniject
6.2.1.7. Recent Developments
6.2.1.8. Future Outlook

6.2.2. West Pharmaceutical
6.2.2.1. Company Overview
6.2.2.2. Financial Performance
6.2.2.3. Prefilled Technology Solutions
6.2.2.4. Plastic Barrel Prefilled Systems
6.2.2.4.1. Daikyo Crystal Zenith Polymer RTU Prefilled Syringe
6.2.2.5. Drug Reconstitution Systems
6.2.2.6. Recent Developments
6.2.2.7. Future Outlook

6.3. Key Prefilled Syringe Manufacturers Based in Europe
6.3.1. Gerresheimer
6.3.1.1. Company Overview
6.3.1.2. Financial Performance
6.3.1.3. Prefilled Technology Solutions
6.3.1.4. Glass Barrel Prefilled Systems
6.3.1.4.1. Gx Glass Syringes
6.3.1.5. Plastic Barrel Prefilled Systems
6.3.1.5.1. ClearJect Prefilled syringes
6.3.1.5.2. Gx RTF Clearject Needle Syringe
6.3.1.6. Safety Syringes
6.3.1.6.1. Gx InnoSafe Safety Syringes
6.3.1.7. Self-Injection Devices
6.3.1.8. Recent Developments
6.3.1.9. Future Outlook

6.3.2. Ompi
6.3.2.1. Company Overview
6.3.2.2. Financial Performance
6.3.2.3. Glass Barrel Prefilled Systems
6.3.2.3.1. EZ-Fill Syringes
6.3.2.3.1.1. EZ-fill Fina
6.3.2.3.1.2. EZ-fill Nexa
6.3.2.3.1.3. EZ-fill Alba
6.3.2.4. Recent Developments
6.3.2.5. Future Outlook

6.3.3. Schott
6.3.3.1. Company Overview
6.3.3.2. Financial Performance
6.3.3.3. Glass Barrel Prefilled Syringes
6.3.3.3.1. syriQ Glass Syringes
6.3.3.4. Plastic Barrel Prefilled Syringes
6.3.3.4.1. TopPac Polymer Syringes
6.3.3.5. Recent Developments
6.3.3.6. Future Outlook

6.4. Key Prefilled Syringe Manufacturers in Asia
6.4.1. Nipro (Acquired MGlas)
6.4.1.1. Company Overview
6.4.1.2. Financial Performance
6.4.1.3. Glass Barrel Prefilled Systems
6.4.1.4. Recent Developments
6.4.1.5. Future Outlook

6.4.2. WEGO Prefills Pharmaceutical Packaging
6.4.2.1. Company Overview
6.4.2.2. Financial Performance
6.4.2.3. WeGo Glass Prefilled Syringe
6.4.2.4. Weigao Prefilled Flush Syringes
6.4.2.5. Future Outlook

6.4.3. Taisei Kako
6.4.3.1. Company Overview
6.4.3.2. Glass Barrel Prefilled Systems
6.4.3.2.1. VF-Syringe
6.4.3.2.1. SIN-Syringe
6.4.3.3. Plastic Barrel Prefilled System
6.4.3.3.1. ClearJect Syringes
6.4.3.3.2. FULJECT Passive Type Syringe
6.4.3.3.3. Ajex Needleless Injection System
6.4.3.4. Future Outlook

6.4.4. Terumo
6.4.4.1. Company Overview
6.4.4.2. Financial Performance
6.4.4.3. Plastic Barrel Prefilled Syringe
6.4.4.4. Safety Devices: Add-On Devices
6.4.4.5. Recent Developments
6.4.4.6. Future Outlook

6.5. Other Manufacturers
6.5.1. Aguettant
6.5.1.1. Company Overview
6.5.1.2. Prefilled Syringe Portfolio
6.5.1.2.1. Aguettant Prefilled Syringe
6.5.1.3. Recent Developments

6.5.2. Arte
6.5.2.1. Company Overview
6.5.2.2. Prefilled Syringe Portfolio
6.5.2.2.1. Dual Chamber Prefillable Syringe
6.5.2.2.2. Single Chamber Prefillable Syringe

6.5.3. J.O. Pharma (Subsidiary of Otsuka Holdings)
6.5.3.1. Company Overview
6.5.3.2. Prefilled Syringe Portfolio

6.5.4. Pfizer Injectables
6.5.4.1. Company Overview
6.5.4.2. Prefilled Syringe Portfolio
6.5.4.2.1. ABBOJECT Syringe
6.5.4.2.2. Emergency Syringes
6.5.4.2.3. iSecure Syringe System

6.5.5. Shandong Pharmaceutical Glass
6.5.5.1. Company Overview
6.5.5.2. Prefilled Syringe Portfolio

6.5.6. Shandong Zibo Minkang Pharmaceutical packing
6.5.6.1. Company Overview
6.5.6.2. Prefilled Syringe Portfolio

6.5.7. Vetter Pharma
6.5.7.1. Company Overview
6.5.7.2. Prefilled Syringe Portfolio
6.5.7.2.1. Lyo-Ject Glass Prefilled Syringe
6.5.7.2.2. Vetter-Ject Safety Device
6.5.7.2.3. V-OVS Safety Device
6.5.7.3. Recent Developments

7 NEEDLESTICK INJURIES
7.1. Chapter Overview
7.2. Incidence and Associated Financial Burden
7.3. Government Legislations for Prevention of Needlestick Injuries

7.4. Safety Mechanisms Used in Modern Prefilled Syringes
7.4.1. Safety Systems: Add-On Safety Device Manufacturers
7.4.1.1. Becton Dickinson
7.4.1.2. Catalent
7.4.1.3. Terumo
7.4.1.4. Tip-Top
7.4.1.5. West Pharmaceutical

7.4.2. Safety Systems: Integrated Safety Device Manufacturers
7.4.2.1. Gerresheimer
7.4.2.2. Injecto
7.4.2.3. MedicalChain International
7.4.2.4. OMPI
7.4.2.5. Owen Mumford
7.4.2.6. SHL Group
7.4.2.7. Taisei Kako

8 REGULATORY LANDSCAPE FOR PREFILLED SYRINGES
8.1. Chapter Overview
8.2. Regulatory Approval of Combination Products in the US
8.2.1. Overview
8.2.2. Historical Background
8.2.3. Regulatory Bodies and their Role in Product Approval
8.2.4. Regulatory Approval for Prefilled Syringes

8.3. Regulatory Approval of Combination Products in Europe
8.3.1. Overview
8.3.2. Regulatory Bodies and their Role in Product Approval
8.3.3. Regulatory Approval for Prefilled Syringes

8.4. Regulatory Approval of Combination Products in Canada
8.4.1. Overview
8.4.2. Regulatory Bodies and their Role in Product Approval
8.4.3. Regulatory Approval for Prefilled Syringes

8.5. Regulatory Approval of Combination Products in Brazil
8.5.1. Overview
8.5.2. Regulatory Bodies and their Role in Product Approval
8.5.3. Regulatory Approval for Prefilled Syringes

8.6. Regulatory Approval of Combination Products in Mexico
8.6.1. Overview
8.6.2. Regulatory Bodies and their Role in Product Approval
8.6.3. Regulatory Approval for Prefilled Syringes

8.7. Regulatory Approval of Combination Products in Argentina
8.7.1. Overview
8.7.2. Regulatory Bodies and their Role in Product Approval
8.7.3. Regulatory Approval for Prefilled Syringes

8.8. Regulatory Approval of Combination Products in Australia
8.8.1. Overview
8.8.2. Regulatory Bodies and their Role in Product Approval
8.8.3. Regulatory Approval for Prefilled Syringes

8.9. Regulatory Approval of Combination Products in Japan
8.9.1. Overview
8.9.2. Regulatory Bodies and their Role in Product Approval
8.9.3. Regulatory Approval for Prefilled syringes

8.10. Regulatory Approval of Combination Products in China
8.10.1. Overview
8.10.2. Regulatory Bodies and their Role in Product Approval
8.10.3. Regulatory Approval for Prefilled syringes

8.11. Regulatory Approval of Combination Products in India
8.11.1. Overview
8.11.2. Regulatory Bodies and their Role in Product Approval
8.11.3. Regulatory Approval for Prefilled Syringes

8.12. Regulatory Approval of Combination Products in South Korea
8.12.1. Overview
8.12.2. Regulatory Bodies and their Role in Product Approval
8.12.3. Regulatory Approval for Prefilled Syringes

8.13. Regulatory Approval of Combination Products in Saudi Arabia
8.13.1. Overview
8.13.2. Regulatory Bodies and their Role in Product Approval
8.13.3. Regulatory Approval for Prefilled Syringes

8.14. Regulatory Approval of Combination Products in United Arab Emirates
8.14.1. Overview
8.14.2. Regulatory Bodies and their Role in Product Approval
8.14.3. Regulatory Approval for Prefilled Syringes

9 PREFILLED SYRINGE COMBINATION PRODUCTS: MARKET OVERVIEW
9.1. Chapter Overview
9.2. Prefilled Syringe Combination Products: List of Approved Drugs, 2013-2019
9.2.1. Analysis by Type of Drug Molecule
9.2.2. Analysis by Approval Year
9.2.3. Analysis by Route of Administration
9.2.4. Analysis by Target Therapeutic Area
9.2.5. Prefilled Syringe Combination Products: Additional Information
9.2.5.1. Analysis by Dose Strength
9.2.5.2. Analysis by Other Approved Dosage Forms

9.3. Prefilled Syringe Combination Products: List of Clinical Stage Drugs, 2013-2019
9.3.1. Analysis by Type of Drug Molecule
9.3.2. Analysis by Phase of Development
9.3.3. Analysis by Route of Administration
9.3.4. Analysis by Target Therapeutic Area

9.4. Prefilled Syringe Combination Products: List of Developers
9.4.1. Analysis by Year of Establishment
9.4.2. Analysis by Company Size
9.4.3. Analysis by Geographical Location of Headquarters

9.5. Leading Drugs in Prefilled Syringes
9.6. Other Drugs Available in Prefilled Syringes
9.7. Popular Drugs in Prefilled Syringes: Case Studies
9.7.1. HUMIRA® (Adalimumab), AbbVie / Eisai
9.7.1.1. Target Indications and Available Dosage Forms
9.7.1.2. Shift from Vials to Syringes
9.7.2. Enbrel® (Etanercept), Amgen / Pfizer / Takeda
9.7.2.1. Target Indications and Available Dosage Forms
9.7.2.2. Shift from Vials to Syringes

10 KEY THERAPEUTIC AREAS
10.1. Chapter Overview
10.1.1. Autoimmune Disorders
10.1.1.1. Approved Injectables
10.1.1.2. Biosimilars

10.1.2. Infectious Diseases
10.1.2.1. Antiviral Drugs
10.1.2.1.1. Approved Injectables
10.1.2.1.2. Biosimilars
10.1.2.2. Vaccines
10.1.2.2.1. Approved Injectables

10.1.3. Neurological Disorders
10.1.3.1. Approved Injectables
10.1.3.2. Biosimilars

10.1.4. Metabolic Disorders
10.1.4.1. Approved Injectables
10.1.4.2. Biosimilars

11 PREFILLED SYRINGES: LIKELY DRUG CANDIDATES AND PARTNER ANALYSIS
11.1. Chapter Overview
11.2. Likely Drug Candidates
11.2.1. Methodology and Key Parameters

11.3. Marketed Drug Candidates
11.3.1. Most Likely Candidates for Delivery via Prefilled Syringes
11.3.2. Likely Candidates for Delivery via Prefilled Syringes
11.3.3. Less Likely Candidates for Delivery via Prefilled Syringes
11.3.4. Least Likely Candidates for Delivery via Prefilled Syringes

11.4. Clinical Drug Candidates
11.4.1. Most Likely Candidates for Delivery via Prefilled Syringes
11.4.2. Likely Candidates for Delivery via Prefilled Syringes
11.4.3. Less Likely Candidates for Delivery via Prefilled Syringes
11.4.4. Least Likely Candidates for Delivery via Prefilled Syringes

11.5. Potential Strategic Partners
11.5.1. Methodology and Key Parameters
11.5.2. Opportunities in North America
11.5.2.1. Most Likely Partners for Prefilled Syringes Combination Product Development
11.5.2. 2. Likely Partners for Prefilled Syringes Combination Product Development
11.5.2.3. Less Likely Partners for Prefilled Syringes Combination Product Development
11.5.2.4. Least Likely Partners for Prefilled Syringes Combination Product Development

11.5.3. Opportunities in Europe
11.5.3.1. Most Likely Partners for Prefilled Syringes Combination Product Development
11.5.3.2. Likely Partners for Prefilled Syringes Combination Product Development
11.5.3.3. Less Likely Partners for Prefilled Syringes Combination Product Development
11.5.3.4. Least Likely Partners for Prefilled Syringes Combination Product Development

11.5.4. Opportunities in Asia-Pacific and Rest of the World
11.5.4.1. Most Likely Partners for Prefilled Syringes Combination Product Development
11.5.4.2. Likely Partners for Prefilled Syringes Combination Product Development
11.5.4.3. Less Likely Partners for Prefilled Syringes Combination Product Development
11.5.4.4. Least Likely Partners for Prefilled Syringes Combination Product Development

12 BIG PHARMA INITIATIVES: PREFILLED SYRINGE COMBINATION PRODUCTS AND LIKELY CANDIDATES
12.1. Chapter Overview
12.2. Methodology
12.3. Top Pharmaceutical Companies
12.3.1. Analysis by Therapeutic Area
12.3.1.1. Autoimmune Disorders
12.3.1.2. Infectious Diseases
12.3.1.3. Oncological Disorders
12.3.1.4. Metabolic Disorders
12.3.1.5. Neurological Disorders
12.3.1.6. Inflammatory Disorders
12.3.1.7. Orthopedic Disorders
12.3.1.8. Others

12.3.2. Analysis by Type of Molecule
12.3.2.1. Antibodies
12.3.2.2. Vaccines
12.3.2.3. Proteins
12.3.2.4. Others

13 SPECIALTY PREFILLED SYRINGES
13.1. Chapter Overview
13.2. Prefilled Flush Syringes
13.2.1. Overview
13.2.2. Prefilled Flush Syringes Available in the Market
13.2.3. Advantages of Prefilled Flush Syringes

13.3. Prefilled Diluent Syringes
13.3.1. Overview
13.3.2. Lyophilized Drugs Available in Prefilled Diluent Syringes
13.3.3. Advantages of Prefilled Diluent Syringes
13.4. Contrast Agent Prefilled Syringes
13.4.1. Overview
13.4.2. Contrast Agents Available in Prefilled Syringes
13.4.3. Advantages of Contrast Agent Prefilled Syringes

14 RECENT DEVELOPMENTS AND APPLICATIONS OF PREFILLED SYRINGES
14.1. Chapter Overview
14.2. Prefilled Syringes For Lyophilized Drugs
14.2.1. Prefilled Diluent Syringes
14.2.2. Prefilled Dual / Multi-Chamber Prefilled Syringes
14.2.2.1. Lyophilized Drugs Available in Dual / Multi-Chamber Prefilled Syringes
14.2.2.2. Prefilled Dual-Chambered Prefilled Pen Injectors for Lyophilized Drugs

14.3. Prefilled Syringes for Ophthalmic Delivery
14.4. Prefilled Syringes for Dermal Fillers
14.5. Multilayer Plastic Prefilled Syringes with Oxygen Barrier
14.6. Prefilled Syringes with Low Particle Formation Risk
14.7. Lubrication Technology for Prefilled Syringes

14.8. Advances in Terminal Sterilization of Prefilled Syringes
14.8.1. Noxilizer’s Nitrogen Dioxide Sterilization Technology
14.9. Prefilled Syringe Usage Aids for patients and Healthcare Providers

15 MARKET SIZING AND OPPORTUNITY ANALYSIS
15.1. Chapter Overview
15.2. Scope and Methodology
15.3. Global Prefilled Syringes Market, 2020-2030
15.3.1. Prefilled Syringes Market: Distribution by Therapeutic Area
15.3.1.1. Prefilled Syringes Market: Autoimmune Disorders
15.3.1.2. Prefilled Syringes Market: Infectious Diseases
15.3.1.3. Prefilled Syringes Market: Neurological Disorders
15.3.1.4. Prefilled Syringes Market: Blood Disorders
15.3.1.5. Prefilled Syringes Market: Oncological Disorders
15.3.1.6. Prefilled Syringes Market: Psychiatric Diseases
15.3.1.7. Prefilled Syringes Market: Respiratory Disorders
15.3.1.8. Prefilled Syringes Market: Cardiovascular Disorders
15.3.1.9. Prefilled Syringes Market: Metabolic Disorders
15.3.1.10. Prefilled Syringes Market: Ophthalmic Disorder
15.3.1.11. Prefilled Syringes Market: Orthopedic Disorders
15.3.1.12. Prefilled Syringes Market: Other Diseases

15.3.2. Prefilled Syringes Market: Distribution by Type of Syringe Barrel Material
15.3.2.1. Prefilled Syringes Market: Glass Barrel Prefilled Syringes
15.3.2.2. Prefilled Syringes Market: Plastic Barrel Prefilled Syringes

15.3.3. Prefilled Syringes Market: Distribution by Type of Chamber System
15.3.3.1. Prefilled Syringes Market: Single Chamber Prefilled Syringes
15.3.3.2. Prefilled Syringes Market: Dual Chamber Prefilled Syringes

15.3.4. Prefilled Syringes Market: Distribution by Type of Drug Molecule
15.3.4.1. Prefilled Syringes Market: Antibodies
15.3.4.2. Prefilled Syringes Market: Proteins
15.3.4.3. Prefilled Syringes Market: Peptides
15.3.4.4. Prefilled Syringes Market: Small Molecules
15.3.4.5. Prefilled Syringes Market: Vaccines

15.3.5. Prefilled Syringes Market: Distribution by Geography
15.3.5.1. Prefilled Syringes Market: North America
15.3.5.2. Prefilled Syringes Market: Europe
15.3.5.3. Prefilled Syringes Market: Asia Pacific
15.3.5.4. Prefilled Syringes Market: Latin America
15.3.5.5. Prefilled Syringes Market: Middle East and Africa

15.3.6. Prefilled Syringes Market: Distribution by Specialty Syringes
15.3.7. Prefilled Syringes Market for Autoimmune Disorders
15.3.7.1. Distribution by Syringe Barrel Material
15.3.7.1.1. Glass Barrel Prefilled Syringes
15.3.7.1.2. Plastic Barrel Prefilled Syringes
15.3.7.2. Distribution by Type of Chamber System
15.3.7.2.1. Single Chamber Prefilled Syringes
15.3.7.2.2. Dual Chamber Prefilled Syringes
15.3.7.3. Distribution by Type of Drug Molecule
15.3.7.3.1. Antibodies
15.3.7.3.2. Proteins
15.3.7.3.3. Small Molecules
15.3.7.4. Distribution by Geography
15.3.7.4.1. North America
15.3.7.4.2. Europe
15.3.7.4.3. Asia Pacific
15.3.7.4.4. Latin America
15.3.7.4.5. Middle East and Africa

15.3.8. Prefilled Syringes Market For Infectious Disorders
15.3.8.1. Distribution by Type of Syringe Barrel Material
15.3.8.1.1. Glass Barrel Prefilled Syringes
15.3.8.1.2. Plastic Barrel Prefilled Syringes
15.3.8.2. Distribution by Type of Chamber System
15.3.8.2.1. Single Chamber Prefilled Syringes
15.3.8.2.2. Dual Chamber Prefilled Syringes
15.3.8.3. Distribution by Type of Drug Molecule
15.3.8.3.1. Vaccines
15.3.8.4. Distribution by Geography
15.3.8.4.1. North America
15.3.8.4.2. Europe
15.3.8.4.3. Asia Pacific
15.3.8.4.4. Latin America
15.3.8.4.5. Middle East and Africa

15.3.9. Prefilled Syringes Market For Neurological Disorders
15.3.9.1. Distribution by Type of Syringe Barrel Material
15.3.9.1.1. Glass Barrel Prefilled Syringes
15.3.9.1.2. Plastic Barrel Prefilled Syringes
15.3.9.2. Distribution by Type of Chamber System
15.3.9.2.1. Single Chamber Prefilled Syringes
15.3.9.2.2. Dual Chamber Prefilled Syringes
15.3.9.3. Distribution by Type of Drug Molecule
15.3.9.3.1. Antibodies
15.3.9.3.2. Proteins
15.3.9.3.3. Peptides
15.3.9.4. Distribution by Geography
15.3.9.4.1. North America
15.3.9.4.2. Europe
15.3.9.4.3. Asia Pacific
15.3.9.4.4. Latin America
15.3.9.4.5. Middle East and Africa

15.3.10. Prefilled Syringes Market For Blood Disorders
15.3.10.1. Distribution by Type of Syringe Barrel Material
15.3.10.1.1. Glass Barrel Prefilled Syringes
15.3.10.1.2. Plastic Barrel Prefilled Syringes
15.3.10.2. Distribution by Type of Chamber System
15.3.10.2.1. Single Chamber Prefilled Syringes
15.3.10.2.2. Dual Chamber Prefilled Syringes
15.3.10.3. Distribution by Type of Drug Molecule
15.3.10.3.1. Proteins
15.3.10.3.2. Small Molecules
15.3.10.4. Distribution by Geography
15.3.10.4.1. North America
15.3.10.4.2. Europe
15.3.10.4.3. Asia Pacific
15.3.10.4.4. Latin America
15.3.10.4.5. Middle East and Africa

15.3.11. Prefilled Syringes Market For Oncological Disorders
15.3.11.1. Distribution by Type of Syringe Barrel Material
15.3.11.1.1. Glass Barrel Prefilled Syringes
15.3.11.1.2. Plastic Barrel Prefilled Syringes
15.3.11.2. Distribution by Type of Chamber System
15.3.11.2.1. Single Chamber Prefilled Syringes
15.3.11.2.2. Dual Chamber Prefilled Syringes
15.3.11.3. Distribution by Type of Drug Molecule
15.3.11.3.1. Antibodies
15.3.11.3.2. Proteins
15.3.11.3.3. Peptides
15.3.11.3.4. Small Molecules
15.3.11.3.5. Vaccines
15.3.11.4. Distribution by Geography
15.3.11.4.1. North America
15.3.11.4.2. Europe
15.3.11.4.3. Asia Pacific
15.3.11.4.4. Latin America
15.3.11.4.5. Middle East and Africa

15.3.12. Prefilled Syringes Market For Metabolic Disorders
15.3.12.1. Distribution by Type of Syringe Barrel Material
15.3.12.1.1. Glass Barrel Prefilled Syringes
15.3.12.1.2. Plastic Barrel Prefilled Syringes
15.3.12.2. Distribution by Type of Chamber System
15.3.12.2.1. Single Chamber Prefilled Syringes
15.3.12.2.2. Dual Chamber Prefilled Syringes
15.3.12.3. Distribution by Type of Drug Molecule
15.3.12.3.1. Proteins
15.3.12.3.2. Peptides
15.3.12.4. Distribution by Geography
15.3.12.4.1. North America
15.3.12.4.2. Europe
15.3.12.4.3. Asia Pacific
15.3.12.4.4. Latin America
15.3.12.4.5. Middle East and Africa
15.3.13. Prefilled Syringes Market For Other Disorders
15.3.13.1. Distribution by Type of Syringe Barrel Material
15.3.13.1.1. Glass Barrel Prefilled Syringes
15.3.13.1.2. Plastic Barrel Prefilled Syringes
15.3.13.2. Distribution by Type of Chamber System
15.3.13.2.1. Single Chamber Prefilled Syringes
15.3.13.2.2. Dual Chamber Prefilled Syringes
15.3.13.3. Distribution by Type of Drug Molecule
15.3.13.3.1. Antibodies
15.3.13.3.2. Proteins
15.3.13.3.3. Peptides
15.3.13.3.4. Small Molecules
15.3.13.4. Distribution by Geography
15.3.13.4.1. North America
15.3.13.4.2. Europe
15.3.13.4.3. Asia Pacific
15.3.13.4.4. Latin America
15.3.13.4.5. Middle East and Africa

16 GROWTH DRIVERS
16.1. Chapter Overview
16.2. Rising Incidence of Chronic Diseases
16.3. Growing Preference for Self-Injection
16.4. Evolving Patient Demographics
16.5. Growth of Biologics and Biosimilars Market
16.6. Changing Pharmaceutical Strategies
16.7. Increasing Focus on Prevention of Needlestick Injuries
16.8. Prefilled Syringes in Autoinjectors and Pen Injectors

17 SWOT ANALYSIS
17.1. Chapter Overview
17.2. Strengths
17.3. Weaknesses
17.4. Opportunities
17.5. Threats
17.6. Concluding Remarks

18 PREFILLED SYRINGE COMPONENT MANUFACTURERS
18.1. Chapter Overview
18.2. List of Component Manufacturers
18.3. Aptar Pharma (a Part of AptarGroup)
18.3.1. Company Overview
18.3.2. Financial Performance
18.3.3. Product Portfolio
18.3.4. Recent Developments and Future Outlook

18.4. West Pharmaceutical
18.4.1. Company Overview
18.4.2. Financial Performance
18.4.3. Product Portfolio
18.4.4. Recent Developments and Future Outlook

18.5. Datwyler Sealing Solutions (a Part of Datwyler Group)
18.5.1. Company Overview
18.5.2. Financial Performance
18.5.3. Product Portfolio
18.5.4. Recent Developments and Future Outlook

18.6. Lonstroff (a Part of Sumitomo Rubber Industries)
18.6.1. Company Overview
18.6.2. Financial Performance
18.6.3. Product Portfolio
18.6.4. Recent Developments and Future Outlook

18.7. Ompi (a Part of Stevanato Group)
18.7.1. Company Overview
18.7.2. Product Portfolio
18.7.3. Recent Developments and Future Outlook

18.8. Jiangsu Hualan Pharmaceutical New Material
18.8.1. Company Overview
18.8.2. Product Portfolio
18.8.3. Recent Developments and Future Outlook

19 FILL / FINISH SERVICE PROVIDERS FOR PREFILLED SYRINGES
19.1. Chapter Overview
19.2. Fill / Finish Processing of Prefilled Syringes
19.2.1. Steps Involved in Fill / Finish Process
19.2.2. Methods of Filling and Stoppering of Prefilled Syringes
19.2.3. Prefilled Syringe Filling Technologies

19.3. Outsourcing of Fill / Finish Operations
19.4. Growth Considerations
19.5. Prefilled Syringes: List of Fill / Finish Service Providers
19.5.1. Analysis by Year of Establishment
19.5.2. Analysis by Geographical Location of Headquarters and Type of Drug Molecule
19.5.3. Analysis by Scale of Operation

20 CASE STUDY: AUTOINJECTORS
20.1. Chapter Overview
20.2. Autoinjectors: Market Overview

20.3. Key Players
20.3.1. Elcam Medical (E3D Elcam Drug Delivery Devices)
20.3.1.1. Company Overview
20.3.1.2. Product Portfolio

20.3.2. Nuance Designs
20.3.2.1. Company Overview
20.3.2.2. Product Portfolio

20.3.3. Owen Mumford
20.3.3.1. Company Overview
20.3.3.2. Product Portfolio

20.3.4. Scandinavian Health Limited (SHL) Group
20.3.4.1. Company Overview
20.3.4.2. Product Portfolio

20.3.5. Union Medico
20.3.5.1. Company Overview
20.3.5.2. Product Portfolio

20.3.6. Ypsomed
20.3.6.1. Company Overview
20.3.6.2. Product Portfolio

21 CONCLUDING REMARKS
21.1. Chapter Overview
21.2. Key Takeaways

22 INTERVIEW TRANSCRIPTS
22.1. Chapter Overview
22.2. Oval Medical Technologies
22.2.1. Company Snapshot
22.2.2. Interview Transcript: Matthew Young, Founder and Chief Technology Officer

22.3. Intas Pharmaceuticals
22.3.1. Company Snapshot
22.3.2. Interview Transcript: Kirti Maheshwari, Chief Technical Officer

22.4. IDT Biologika
22.4.1. Company Snapshot
22.4.2. Interview Transcript: Gregor Kawaletz, Chief Commercial Officer

22.5. West Pharmaceutical
22.5.1. Company Snapshot
22.5.2. Interview Transcript: Kevin Cancelliere and Tibor Hlobik, Marketing Directors

22.6. Lonstroff
22.6.1. Company Snapshot
22.6.2. Interview Transcript: Marco Pederiva, Marketing and Sales Directors

22.7. IDEO
22.7.1. Company Snapshot
22.7.2. Interview Transcript: Jesse Fourt, Design Directors

22.8. Small-sized Medical Device Company
22.8.1. Interview Transcript: Anonymous, Chief Executive Officer

23 APPENDIX 1: TABULATED DATA

24 APPENDIX 2: LIST OF COMPANIES

Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]